chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Left leg became very swollen around 6 inches in diameter. Pt also has experienced a fever for 4 days up to 103. She also was experiencing a bad headache.
Patient complains of tingling in face, ears, & head, after flu injection in the left deltoid @1530. Notified the Clinics Physician. The physician assessed the patient - @1600.
Left patient message. Patient should not have received a booster of Pfizer after receiving 3 doses of Sinovax. Patient received Pfizer booster on 04/25/22.
first dose / on Oct 23 2020 / has not received the 2nd dose yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 23rd October 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report.   The pharmacist asked should patient receive the 2nd dose of Shingrix at the time of reporting. Till the time of reporting the patient did not receive the 2nd dose of Shingrix,which led to incomplete course of vaccination. The reporter consented to follow up. The HCP (health care professional) declined to leave any additional patient details.
Body aches; Not feeling very good; Not a lot of energy; This case was reported by a consumer and described the occurrence of general body pain in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th October 2019, the patient received Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced general body pain, feeling bad and loss of energy. On an unknown date, the outcome of the general body pain, feeling bad and loss of energy were unknown.   It was unknown if the reporter considered the general body pain, feeling bad and loss of energy to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and not feeling well and had body aches and not a lot of energy.
Information has been received from a registered dietician concerning a 78 year old female inpatient with hypertension, arthritis and leaky valve of heart, drug reaction/allergies to penicillin and naproxen who in May 2008, "3 years ago", was vaccinated with a dose of PNEUMOVAX 23 (lot number not reported) while in the hospital for an unrelated condition. Concomitant therapy included TOPROL XL TABLETS, DYAZIDE and PREMARIN. In May 2008, "3 years ago", the patient's arm immediately became swollen, "it was very significant." She did not know how long the swelling lasted but denied any difficulty breathing. The patient was given cold packs only due to other medical problems at that time. On an unspecified date, the patient recovered from her arm immediately became swollen. The patient sought medical attention while an inpatient at the hospital. Additional information has been requested.
Swollen knees and hip pain..no injuries noted... 2wks duration went for PT and compression
1) increasing soreness of vaccination site.  2) Loss of muffled hearing in both ears. It felt like my ear canals were swelling up. Hearing was impaired, it sounded like I had ear plugs in my ears. I could still hear but  not clearly.  I took Ibuprofen 200mg for arm soreness and Pseudoephedrine HCl 30mg as decongestant for ear canal swelling. arm soreness decreased in 30 minutes. Hearing was the same. The next morning, hearing was normal.
Starting approximately 7-10 days after vaccine, I developed a chronic inflammation within my nasal passages. It was a condition wherein a scab or crust developed on the mucous membranes within my nose. If I blew my nose hard, the crusts would break off and bleed. They were basically chronic, painful scabs within my nose that lasted approximately 3 months. If I 'bumped' my nose on something (such as my dog's large head hitting my nose), it would be quite painful. If I gently squeezed my nose with my fingers, it would hurt quite a bit. I had never had a symptom like this in my entire life and in my opinion it was directly related to the vaccine I received. The symptoms slowly went away, the scabs eventually disappeared after approximately 3 months.
Systemic: Shakiness-Severe, Additional Details: patient had shakiness. He said he was very nervous and anxious about vaccination. He sat for few mins was given water and candy. He wanted to stand outside for few mins and felt better was feeling better when he went outside.
Very large red skin rash at injection site about 3-4 inch  in diameter. Hot , swollen this happened at day 2 after second shot of Moderna
Parsonage Turner Syndrome  began 2 days after vaccination. Shoulder affected was same side as injection. Extreme shoulder pain lasted 2.5 weeks followed by muscle weakness. Could not use arm as normal. Visited an Orthopedic Surgeon who ordered an MRI.  MRI did not show any major damage that would cause these symptoms and recommended testing for Parsonage Turner Syndrome. Diagnosis confirmed after EMG conducted by neurologist. Still recovering.
pt recv vax 17SEP96 returned to office 20SEP96 pt exp sore throat, reported low fever, swallowing lymph nodes @ throat;tonsils enlarged & deep red;rash on face, trunk, spreading to arms & legs;maculopapular to confluent discharged;nasal con
push out the second dose to 4 weeks,; This is a spontaneous report from a contactable consumer or other non hcp. A 20-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration on 13May2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient's medical history included COVID-19 on Labor Day weekend, and she had antibodies 8 months later that were still present. The patient's concomitant medications were not reported. The patient experienced push out the second dose to 4 weeks. She states that they would like to have an appointment with the cardiologist prior to her receiving the second dose of the vaccine so she would like to know if they could push out the second dose to 4 weeks, on 11Jun2021. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Events of 7 Jan 21 (~15 hrs after first dose) 0600 - woken by cold chills/shivering 0800 - chills subsided, but tingling sensation similar to drinking a large energy drink (ie. Monster) 1000 - muscle and joint aches throughout body, mild chills, very fatigued  1200 - headache begins.  No change to muscle/joint pain, chills, or fatigue.  Take ibuprofen for pain 1400 - peak of all pain and fatigue with massive headache, shivering chills and tingling throughout surface of skin.  Very hard to focus on tasks. 1600 - most of the pain has gone away and barely noticeable.  Headache, chills and tingling have mostly gone away. 1800 - all prior symptoms cleared.  Only thing remaining is soreness where vaccine was injected. 8 Jan 21 0730 - After 9 hours of sleep, all symptoms remain cleared. 2200 - all symptoms remain cleared.  Injection site soreness barely noticeable.
This spontaneous report was received from a medical assistant regarding a patient of unknown age and gender. Information on the medical history, concurrent conditions and drug allergies of the patient was not reported. On 02-AUG-2016 the patient was vaccinated with improperly stored dose of PROQUAD lot # L051100, expiry date 17-JUN-2017, 0.5 ml, subcutaneously (incorrect product storage). Concomitant medication were not reported. No adverse effects were reported. There was no Product Quality Complaint (PQC) involved. Temperature and time frame at which the administered vaccine was stored was -0.15 degree Centigrade for 5 hours. Additional information has been requested.
lower back hurts; calves were hurting; soreness in hips; chills; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (lower back hurts), PAIN IN EXTREMITY (calves were hurting), ARTHRALGIA (soreness in hips) and CHILLS (chills) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced CHILLS (chills). On 19-Feb-2021, the patient experienced BACK PAIN (lower back hurts), PAIN IN EXTREMITY (calves were hurting) and ARTHRALGIA (soreness in hips). At the time of the report, BACK PAIN (lower back hurts), PAIN IN EXTREMITY (calves were hurting), ARTHRALGIA (soreness in hips) and CHILLS (chills) outcome was unknown.
Patient reports feeling lightheaded/dizzy immediately after parking car in the observation lot.  EMS arrived, patient was pale & diaphoretic, fatigued, bradycardic (52) but patient states that was not much lower than his usual resting heart rate.  At 1502 patient's color was improving and he stated he was feeling much better.  At 1509 patient reports he is feeling back to baseline.  At 1515 patient is cleared by EMS.  Patient advised to remain on site for an additional 15 minute minimum for monitoring.  Advised patient to call his PCP. 911, or go to the nearest emergency room for any further issues.  Recommended patient to sign up for on Vsafe. Patient remained until 1530 and left the site.
At 1645 on 10/02/17, patient started having a persistent cough accompanied by a feeling of a "hard time breathing". Within fifteen minutes the cough had increased in frequency and severity to where she felt congested even, At that time she developed pain in the back of her neck accompanied by a headache and dizziness. Denies facial or oral swelling. Contemplated on going to the hospital. Instead she took 50 mg. of Benadryl by mouth. At 1830 she also took 800 mg. Motrin by mouth. At 1845 she felt warm. She checked her temperature- it was 102 F. She took a warm bath as she felt chilled. She did not really feel better with the congested feeling and difficulty breathing until around midnight. Her temperature at that time was down to 101.3 F.She admits to being afraid to lie down- slept at intervals sitting up.  Finally at 0300 of 10/03 she felt better with her breathing and her temperature was decreased to 99 F. She denies having to seek further treatment or medications since.
Irritability, injection site tenderness, decreased sleep, fever, injection site redness, and injection site swelling (increasing per day).
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. There was no medical history or drug reaction/allergies reported. Between the dates of 02-MAR-2015 to August 2015, the patients were vaccinated with doses of improperly stored M-M-R II (lot# was K015375 with expired date 18-SEP-2016, dose and route were unknown). No concomitant medication was provided. No adverse effect was reported. This is one of two reports received from the same reporter (1509USA004852). Additional information has been requested.
Fever 101.1 - 12/9/2021 Fever 100.7 - 12/10/2021 Severe headache 12/9-12/11 Arm swollen, rashy, itchy - 12/10-12/12 +ongoing Fever has subsided
Right deltoid area patchy areas of erythema and edema, mildly tender to touch, color change. Patient instructed in use and dosing of analgesics. Instructed to apply ice 20 min every hour for next 24-48 hours. Return to clinic if symptoms worsening.
This spontaneous report as received from a licensed practical nurse refers to the unknown number of patients of unknown age and gender. No information on the patients' concomitant medications, concurrent conditions, pertinent medical history, drug reactions or allergies was reported. On 03-NOV-2016 and on 04-NOV-2016, the patients were orally administered improperly stored doses of ROTATEQ oral liquid (lot # M019690 with expiry date on 02-NOV-2017; lot # M014318 with expiry date on 30-SEP-2017; lot # M031802 with expiry date on 09-NOV-2017; dose was not reported). Administered doses of vaccine experienced the temperature excursion of 35 degrees Fahrenheit for 6 hours. Data logger was involved. There were no previous excursions reported. No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
rash is gone now and a little pink; tender, swollen, and itchy; red rash around the site of injection; tender, swollen, and itchy; tender, swollen, and itchy; felt "freezing cold" and "warm and cold."; chills, a slight temperature, and her body hurt all over.; chills, a slight temperature, and her body hurt all over; chills, a slight temperature, and her body hurt all over.; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (felt "freezing cold" and "warm and cold."), SKIN DISCOLOURATION (rash is gone now and a little pink), PAIN (chills, a slight temperature, and her body hurt all over.), VACCINATION SITE PRURITUS (tender, swollen, and itchy) and PYREXIA (chills, a slight temperature, and her body hurt all over.) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (felt "freezing cold" and "warm and cold."), PAIN (chills, a slight temperature, and her body hurt all over.), PYREXIA (chills, a slight temperature, and her body hurt all over.) and CHILLS (chills, a slight temperature, and her body hurt all over). On 07-Mar-2021, the patient experienced SKIN DISCOLOURATION (rash is gone now and a little pink), VACCINATION SITE PRURITUS (tender, swollen, and itchy), INJECTION SITE RASH (red rash around the site of injection), VACCINATION SITE PAIN (tender, swollen, and itchy) and VACCINATION SITE SWELLING (tender, swollen, and itchy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 28-Feb-2021, FEELING OF BODY TEMPERATURE CHANGE (felt "freezing cold" and "warm and cold."), PAIN (chills, a slight temperature, and her body hurt all over.), PYREXIA (chills, a slight temperature, and her body hurt all over.) and CHILLS (chills, a slight temperature, and her body hurt all over) had resolved. On 12-Mar-2021, SKIN DISCOLOURATION (rash is gone now and a little pink), VACCINATION SITE PRURITUS (tender, swollen, and itchy), INJECTION SITE RASH (red rash around the site of injection), VACCINATION SITE PAIN (tender, swollen, and itchy) and VACCINATION SITE SWELLING (tender, swollen, and itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: followup received on 24-may-2021, No new information
Patient Developed welts after influenza vaccine given in office. Pt had noteable hives and 3 spots become present in/at Left side of neck/hairline. Cheek redness, spots on back. No anaphylaxis reaction noted. Administered Benadryl, Zyrtec and Solu-Medrol per MD order. Continues to monitor pt after administering medications. Patient denied shortness of breath, pain, itching and/or trouble breathing. No fever present. Patient had no welts present 15 mins after visit. MD notified. Pt to continue 2 days of steroids and begin daily allergy medication. Encouraged to follow up with any concerns. reaction time total 1hour and 15 mins in office. Pt to be referred for allergy testing. Pt encouraged to go to ER if any symptoms of breathing complications become present.
I experienced abnormal pain during the month of June and when to the ER (was diagnosed with gall stones and had surgery on 07/31/202...gall bladder was removed and showed signs of inflammation). At the same time, I experienced a mild case of Shingles in my left breast area. I was discharged with Percocet after the removal of my gall bladder. The Shingles went away on their own after a couple of days. I am currently experiencing diarrhea when consuming food but otherwise am fine.
covid arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (covid arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (covid arm). At the time of the report, VACCINATION SITE REACTION (covid arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information and concomitant products information was not provided.
3 1/2 year old grandson developed herpes zoster skin lesions two days after exposure to patient getting Zostavax vaccine.
swelling of lymph node; injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swelling of lymph node) and VACCINATION SITE PAIN (injection site pain) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced LYMPHADENOPATHY (swelling of lymph node) and VACCINATION SITE PAIN (injection site pain). On 16-Mar-2021, LYMPHADENOPATHY (swelling of lymph node) and VACCINATION SITE PAIN (injection site pain) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient experienced injection site pain and swelling of lymph node within 5 to 10 hours following the injection. The patient continued to breastfeed.  No relevant concomitant medications were reported.  Treatment information was not provided.
Upper left arm started itching 1/23/21 - 1 week after vaccine...esp. uncomfortable in middle of night...upper left arm developed a red oval about 6x3"...skeing towards inner arm   Still itchy in AM - applied Cortizone middle of night - 1 Zyrtec Tab. 10AM --  Lower back also sore - I attributed it to crawling around on floor yesterday and early this AM working on craft project...took 3 advil and laying down.
Intermittent tinnitus. Previous to injection, would experience 5-10 second high-pitched ringing sounds in ears once or twice a year. Since the vaccine, I've experienced them 5-10 times per week. It's not causing problems, but it's been noticeable and began a couple days after the vaccine. 6 weeks later, and this pattern continues with only a small drop-off in frequency. Again not a disruptive problem, but if this information can assist in finding patterns or helping others with more disruptive issues, I felt it my responsibility to report this side effect.
This spontaneous report was received from a physician referring to a 25 year old female patient. The patient pertinent medical history, concurrent conditions, concomitant therapies and past drug reactions/allergies were not reported. On an unknown date in 2007, the patient was vaccinated with the first dose of GARDASIL (strength, dose, route, anatomical location, lot # and expiration date were not reported) for prophylaxis. Other suspect therapies included GARDASIL 9 (strength, dose, route, anatomical location, lot # and expiration date were not reported) for prophylaxis. The reporter stated that patient received the first dose GARDASIL when she was 15 years old. Per physician, the patient, who was now 25 years old, was in the office to receive the second dose for human papilloma virus (HPV); however, the formulation that is available was GARDASIL 9. No adverse effects reported.
rash to bilateral thighs, took benadryl 25mg po x 1, pepcid 20mg po x 1, dexamethasone 4mg po x 1
On Wednesday, 12/29/21, Patient came to Covid-19 Vaccination Site for her Janssen Covid-19 booster vaccine. Client received her Janssen Covid-19 booster dose (LOT #: 1855191) at 1:12 PM in her left deltoid. During assessment questions, client stated her medical history included migraines and takes ajovy and imitrex for them and no known allergies. Client was to be a 15 minute observation. At 1:16 PM, while waiting in Observation Area, client stated to EMT right after sitting down she felt "dizzy, cold and sweaty with tunnel vision." Client was brought over to sit in anti gravity chair by EMT. At 1:16 PM vitals started, BP: 112/79, HR: 112, O2 sat: 98%, RR: 16, skin: pale, clammy and cool. Client stated she did eat a grilled cheese and soda before vaccination. At 1:25 PM, BP: 110/79, HR: 96, O2 sat: 99%, RR: 16, skin: warm, pink and dry. Client stated she feels "fine" now and experiencing no dizziness. Client did state she experienced a similar sensation after her first Janssen vaccine. Client was offered water which she drank and reclined in anti gravity chair. At 1:33 PM, BP: 112/74, HR: 110, O2 sat: 97%, RR: 16, skin: pink, warm and dry. Client states she feels "back to normal" and experiencing no other symptoms. No further interventions needed. Client was educated by EMT on signs and symptoms of adverse reactions and when to go to the ED/call MD. Client was also encouraged to sign-up for after vaccination health checker. At 1:40 PM, client left vaccination site with a steady gait.
Red rash around the deltoid area with a bullseye appearance; Injection site was tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Red rash around the deltoid area with a bullseye appearance) and VACCINATION SITE PAIN (Injection site was tender) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012120A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE RASH (Red rash around the deltoid area with a bullseye appearance) and VACCINATION SITE PAIN (Injection site was tender). At the time of the report, VACCINATION SITE RASH (Red rash around the deltoid area with a bullseye appearance) and VACCINATION SITE PAIN (Injection site was tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Severe seizures following hep B vaccine, developed severe skin allergies, metabolic issues, severe motor tics. Once we stopped vaccinating and began aggressively detoxing our child, his allergies subsided along with metabolic issues and motor tics.
sore throat, cough, nasal congestion, runny nose, weakness, fatigue, slight difficulty breathing, very slight wheezing, soreness
Pt recv vax on 2/26/99; on 2/28/99 pt exp fever (102) x 2 days, fine macular rash on trunk & scalp x 2 days